Article Details

Pfizer Touts Positive Results From Late-Stage Hemophilia B Gene Therapy Trial - Benzinga

Retrieved on: 2022-12-29 13:54:28

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Touts Positive Results From Late-Stage Hemophilia B Gene Therapy Trial - Benzinga. View article details on hiswai:

Excerpt

Pfizer licensed SPK-9001 (fidanacogene elaparvovec), from Spark Therapeutics under a December 2014 agreement. Price Action: PFE shares are up 0.35% at ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up